mibefradil has been researched along with Coronary Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beltrame, JF; Ganz, P | 1 |
| Beltrame, JF; Horowitz, JD; Leslie, S; Turner, SP | 1 |
| Beltrame, JF; Freedman, SB; Horowitz, JD; Leslie, SL; Solomon, P; Turner, SP | 1 |
| Waeber, B | 1 |
| Stephan, S | 1 |
| Califf, RM; Reimer, KA | 1 |
| Guth, BD | 1 |
| Braat, SH; Gassner, A; Hagemeijer, F; Kraaij, CJ; Portegies, MC; Pozenel, H; Prager, G; Schmitt, R; van der Wall, EE; Viersma, JW | 1 |
| Banken, L; Clozel, JP; Osterrieder, W | 1 |
1 review(s) available for mibefradil and Coronary Disease
| Article | Year |
|---|---|
Potential cardioprotective effect of mibefradil in the long-term treatment of hypertension.
Topics: Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Coronary Disease; Drug Interactions; Follow-Up Studies; Heart Rate; Humans; Hypertension; Mibefradil; Safety; Tetrahydronaphthalenes; Treatment Outcome | 1998 |
2 trial(s) available for mibefradil and Coronary Disease
| Article | Year |
|---|---|
The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.
Topics: Adult; Biomarkers; Blood Flow Velocity; Blood Pressure; C-Reactive Protein; Calcium Channel Blockers; Coronary Angiography; Coronary Disease; Coronary Vessels; Cross-Over Studies; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Conduction System; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Patient Compliance; Statistics as Topic; Systole; Treatment Outcome; Troponin I | 2004 |
Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Coronary Disease; Depression, Chemical; Double-Blind Method; Electrocardiography; Erythrocytes; Exercise Test; Female; Heart Rate; Humans; Male; Mibefradil; Middle Aged; Myocardial Contraction; Radionuclide Ventriculography; Tetrahydronaphthalenes; Ventricular Function, Left | 1991 |
6 other study(ies) available for mibefradil and Coronary Disease
| Article | Year |
|---|---|
Evaluating patients with persistent chest pain and no obstructive coronary artery disease.
Topics: Angina Pectoris; Animals; Blood Flow Velocity; Cardiovascular Agents; Chest Pain; Coronary Circulation; Coronary Disease; Diagnosis, Differential; Humans; Mibefradil; Quality of Life; Randomized Controlled Trials as Topic; Rest; Vasodilator Agents | 2009 |
Mibefradil: "Has the baby been thrown out with the bath water?".
Topics: Angina Pectoris; Calcium Channel Blockers; Calcium Channels, T-Type; Coronary Disease; Coronary Vessels; Drug and Narcotic Control; Humans; Mibefradil; Randomized Controlled Trials as Topic; Verapamil | 2003 |
[Current therapy of coronary heart disease. Conservative measures].
Topics: Adverse Drug Reaction Reporting Systems; Benzimidazoles; Calcium Channel Blockers; Coronary Disease; Evidence-Based Medicine; Humans; Mibefradil; Patient Care Team; Tetrahydronaphthalenes | 1998 |
Good news for experimental concept but bad news for clinically effective therapy.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Coronary Disease; Humans; Mibefradil; Tetrahydronaphthalenes | 1999 |
Reduction of exercise-induced regional contractile dysfunction in dogs using a novel calcium channel blocker (Ro 40-5967).
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Coronary Disease; Dogs; Hemodynamics; Mibefradil; Myocardial Contraction; Physical Conditioning, Animal; Tetrahydronaphthalenes | 1992 |
Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil.
Topics: Animals; Benzimidazoles; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Dogs; Heart; Injections, Intravenous; Mibefradil; Tetrahydronaphthalenes; Verapamil | 1989 |